1. Home
  2. CTOS vs NNNN Comparison

CTOS vs NNNN Comparison

Compare CTOS & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Custom Truck One Source Inc.

CTOS

Custom Truck One Source Inc.

HOLD

Current Price

$6.31

Market Cap

1.4B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$41.73

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTOS
NNNN
Founded
1988
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
CTOS
NNNN
Price
$6.31
$41.73
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
887.2K
34.6K
Earning Date
03-03-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$1,936,513,000.00
$6,920,153.00
Revenue This Year
$13.19
N/A
Revenue Next Year
$4.90
N/A
P/E Ratio
N/A
$700.97
Revenue Growth
7.39
N/A
52 Week Low
$3.18
$5.18
52 Week High
$6.78
$55.65

Technical Indicators

Market Signals
Indicator
CTOS
NNNN
Relative Strength Index (RSI) 57.48 67.54
Support Level $5.82 $32.93
Resistance Level $6.25 $35.40
Average True Range (ATR) 0.20 4.05
MACD 0.04 0.87
Stochastic Oscillator 83.70 100.00

Price Performance

Historical Comparison
CTOS
NNNN

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: